Large Inflow of Money Witnessed in Agilent Technologies

Agilent Technologies (A) : Agilent Technologies (A) had a healthy money flow of $5.66 million into the stock during the Thursdays trading session. The value of bullish trades on upticks was $12.93 million, whereas, investors only sold shares worth $7.27 million on downticks. The stock closed the day with an up-down ratio of 1.78.The money flow in the block trades to the tune of $4.91 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $4.91 million worth of transactions were on upticks. Agilent Technologies (A) stock slid $0.05 intraday and traded at 44.42, a change of -0.11% over previous days close. However, for the week, the company shares are -0.4% compared to previous weeks close.


Agilent Technologies (A) : 8 Wall Street analysts covering Agilent Technologies (A) believe that the average level the stock could reach for the short term is $49.38. The maximum price target given is $55 and the minimum target for short term is around $45, hence the standard deviation is calculated at $3.02. The stock has recorded a 20-day Moving Average of 0.92% and the 50-Day Moving Average is 1.06%.

Agilent Technologies (NYSE:A): The stock opened at $44.47 on Thursday but the bulls could not build on the opening and the stock topped out at $44.74 for the day. The stock traded down to $44.18 during the day, due to lack of any buying support eventually closed down at $44.42 with a loss of -0.11% for the day. The stock had closed at $44.47 on the previous day. The total traded volume was 1,861,536 shares.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.